Page last updated: 2024-08-25

cipamfylline and betamethasone valerate

cipamfylline has been researched along with betamethasone valerate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, C; Engell, K; Felding, J; Hegardt, P; Ladefoged, LG; Larsen, J; Nielsen, SF; Poulsen, TD; Refer, P; Søhoel, A; Sørensen, MD; Thormann, T; Vinggaard, AM	1
Ashikaga, T; de Jongh, GJ; Hornix, M; Kucharekova, M; Schalkwijk, J; T'kint, S; van de Kerkhof, PC; van der Valk, PG	1
Alenius, H; Kemp, K; Kvist, PH; Lauerma, A; Lehto, M; Savinko, T; Wolff, H	1

Reviews

1 review(s) available for cipamfylline and betamethasone valerate

Article	Year
Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis. Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14 Topics: Acetamides; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase 4 Inhibitors; Pyridines; Structure-Activity Relationship	2014

Article

Year

Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis.

Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14

Topics: Acetamides; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase 4 Inhibitors; Pyridines; Structure-Activity Relationship

2014

Trials

1 trial(s) available for cipamfylline and betamethasone valerate

Article	Year
The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis. Archives of dermatological research, 2003, Volume: 295, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Betamethasone Valerate; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Irritant; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythema; Female; Glucocorticoids; Humans; Keratins; Male; Middle Aged; Pilot Projects; Sodium Dodecyl Sulfate; Surface-Active Agents; Water Loss, Insensible; Xanthines	2003

Article

Year

The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.

Archives of dermatological research, 2003, Volume: 295, Issue:1

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Betamethasone Valerate; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Irritant; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythema; Female; Glucocorticoids; Humans; Keratins; Male; Middle Aged; Pilot Projects; Sodium Dodecyl Sulfate; Surface-Active Agents; Water Loss, Insensible; Xanthines

2003

Other Studies

1 other study(ies) available for cipamfylline and betamethasone valerate

Article	Year
A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis. International immunopharmacology, 2010, Volume: 10, Issue:4 Topics: Administration, Topical; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Betamethasone Valerate; Calcineurin Inhibitors; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Enterotoxins; Female; Immunoglobulin A; Immunoglobulin E; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphodiesterase Inhibitors; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Skin; Tacrolimus; Xanthines	2010

Article

Year

A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.

International immunopharmacology, 2010, Volume: 10, Issue:4

Topics: Administration, Topical; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Betamethasone Valerate; Calcineurin Inhibitors; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Enterotoxins; Female; Immunoglobulin A; Immunoglobulin E; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphodiesterase Inhibitors; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Skin; Tacrolimus; Xanthines

2010